Genetics, Subtypes, and Your Test Results
At a Glance
A positive prenatal screen does not confirm Trisomy 13. Diagnostic testing determines whether extra chromosome 13 material is full, mosaic, or attached to another chromosome, while karyotype and microarray provide different details; genetic counseling explains outlook and future pregnancy risk.
To understand Trisomy 13, it helps to start with the basics of genetics. Typically, every cell in the body contains 23 pairs of chromosomes, for a total of 46. One pair—the 13th pair—usually has two copies. Trisomy 13 occurs when there is extra genetic material from the 13th chromosome [1].
However, it is crucial to understand that a positive screening test during pregnancy (such as NIPT or cell-free DNA) is not a confirmed diagnosis. Screening tests assess risk, but definitive answers require diagnostic testing, such as CVS or amniocentesis during pregnancy, or a blood karyotype or microarray after birth [2].
When diagnostic testing confirms Trisomy 13, the report will identify a specific “subtype.” The arrangement of the extra genetic material can significantly influence a child’s health and survival [3].
The Three Genetic Subtypes
- Full Trisomy 13 (Free Trisomy): This is the most common form. It means that an entire extra 13th chromosome is present in every cell that the laboratory tested [3]. On a karyotype (a picture of the chromosomes), this is usually written as 47,XX,+13 (for a girl) or 47,XY,+13 (for a boy) [4].
- Mosaic Trisomy 13: In this form, the extra chromosome is present in some cells, while other cells have the typical two copies [4]. The report might look like a fraction, such as mos 47,XX,+13[11]/46,XX[10], which tells you the ratio of cells found in the sample [5]. Note: The percentage of mosaic cells found in a blood sample does not perfectly predict the percentage in other tissues, like the heart or brain.
- Translocation Trisomy 13: In this form, the extra genetic material is physically attached to another chromosome [2]. This can result in a whole extra 13th chromosome (full trisomy) or only a duplicated segment (Partial Trisomy) depending on the specific structural rearrangement. It is often written with terms like rob (for a Robertsonian translocation) or der (for a derivative chromosome) [6][2].
While Trisomy 13 is a life-limiting condition, survival outcomes vary. Research indicates that children with mosaic or partial variants often have different, sometimes longer, survival trajectories compared to those with full Trisomy 13, though individual outcomes depend heavily on which specific organs are affected [3][7].
Decoding Your Lab Reports
You may see two types of diagnostic tests on your child’s chart:
- Karyotype: A visual map of the physical chromosomes. It is the best test for seeing how chromosomes are arranged and is necessary to identify a structural translocation [2].
- Microarray (CMA): This test is like a high-powered zoom lens. It can detect very tiny extra or missing pieces of DNA (copy-number gains and losses), but it generally cannot show whether that extra material is physically attached to another chromosome (a translocation) [8][4].
Genetic Counseling and Recurrence Risk
It is highly recommended that every family meet with a genetic counselor to discuss their individualized recurrence risk.
If your child’s report shows a Translocation, it is standard medical practice for both biological parents to undergo their own karyotyping [6]. In some translocation cases, a parent may be a “balanced carrier,” meaning they have all the right genetic material but it is shuffled. This significantly increases the risk of passing on an unbalanced translocation in future pregnancies [9][10]. Knowing your own carrier status allows your medical team to give you accurate information about the risk of Trisomy 13 occurring again [11][6].
Even if the test shows “Full” or “Mosaic” Trisomy 13, which are usually random events during cell division, the recurrence risk for future pregnancies is not literally zero. A genetic counselor will help you understand residual risks, including maternal age-related factors and the rare possibility of parental mosaicism [4].
Common questions in this guide
Does a positive NIPT mean my baby definitely has Trisomy 13?
What is the difference between full, mosaic, and translocation Trisomy 13?
How do I read a karyotype result such as 47,XX,+13?
Can the percentage of mosaic Trisomy 13 in blood predict my child’s health?
Why might my child need both a karyotype and a microarray?
Why are parents offered karyotyping after a translocation result?
What is the chance of Trisomy 13 happening again in a future pregnancy?
One line in your results can change your plan.
If the report shows a translocation, karyotyping of both biological parents is standard medical practice. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Trisomy 13 syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Congenital anomalies associated with trisomy 18 or trisomy 13: A registry-based study in 16 European countries, 2000-2011.
Springett A, Wellesley D, Greenlees R, et al.
American journal of medical genetics. Part A 2015; (167A(12)):3062-9 doi:10.1002/ajmg.a.37355.
PMID: 26347425 - 2
Next-generation Sequencing and Karyotype Analysis for the Diagnosis of Robertsonian Translocation Type Trisomy 13: A Case Report.
Sha J, Liu F, Zhang B, et al.
Iranian journal of public health 2017; (46(6)):848-851.
PMID: 28828329 - 3
Long-Term Survival Among Children With Trisomy 13 and Trisomy 18 by Cytogenetic Status.
Ludorf KL, Benjamin RH, Shumate CJ, et al.
JAMA network open 2025; (8(9)):e2529885 doi:10.1001/jamanetworkopen.2025.29885.
PMID: 40920381 - 4
Mosaic proximal trisomy 13q and regular trisomy 13 in a female patient with long survival: Involvement of an incomplete trisomic rescue and a chromothripsis event.
Morán-Barroso VF, Cervantes A, Rivera-Vega MDR, et al.
Molecular genetics & genomic medicine 2021; (9(9)):e1762 doi:10.1002/mgg3.1762.
PMID: 34288579 - 5
Prenatal Sonographic Features of Rare Chromosome 13 Aberrations.
Moczulska H, Pietrusinski M, Serafin M, et al.
The application of clinical genetics 2022; (15()):145-151 doi:10.2147/TACG.S370163.
PMID: 36213554 - 6
Partial Trisomy of Chromosome 13 with a Novel Translocation (8 ; 13) and Unique Clinical Presentation in a Palestinian Infant.
Abuhamda A, Elsous A, Sharif FA
Case reports in medicine 2019; (2019()):4561761 doi:10.1155/2019/4561761.
PMID: 30936921 - 7
Low-level mosaic trisomy 13 at amniocentesis associated with a favorable outcome in a pregnancy.
Chen CP, Chern SR, Wu FT, et al.
Taiwanese journal of obstetrics & gynecology 2020; (59(6)):935-937 doi:10.1016/j.tjog.2020.09.022.
PMID: 33218415 - 8
[The value of combined use of chromosomal karyotyping and chromosome microarray analysis for prenatal diagnosis].
Rao H, Liu Y, Lu Q, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(4)):392-396 doi:10.3760/cma.j.issn.1003-9406.2020.04.007.
PMID: 32219820 - 9
A Case of Trisomy 13 Mosaicism Presenting with a Severe Aortic Root Dilatation and Marfanoid Habitus due to an Unpredictable Cytogenetic Mechanism.
Monin P, Reynaud N, Hanna N, et al.
Cytogenetic and genome research 2020; (160(2)):72-79 doi:10.1159/000506319.
PMID: 32187601 - 10
[Accidental discovery of copy number variation on chromosome 1 in a fetus with high risk of trisomy 13 suggested by NIPT].
Chang J, Song Y, Qi Q, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2023; (40(8)):922-927 doi:10.3760/cma.j.cn511374-20220818-00560.
PMID: 37532489 - 11
Prenatal Diagnosis of Cleft Lip and Palate: A Retrospective Study.
Brăila AD, Damian CM, Albu CC, et al.
Journal of clinical medicine 2024; (13(16)) doi:10.3390/jcm13164804.
PMID: 39200946
This page is for informational purposes only and does not constitute medical advice. It explains Trisomy 13 genetic subtypes and test reports; ask your child’s genetics team to interpret the specific results and recurrence risk.